Pharmaplan India Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 36 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
About Pharmaplan India
Pharmaplan India Private Limited (PIPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 November 1988 and has a history of 36 years and three months. Its registered office is in Delhi, India.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ajay Chauhan and Anand Chauhan serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74899DL1988PTC033847
- Company No.
033847
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Nov 1988
- Date of AGM
05 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Who are the key members and board of directors at Pharmaplan India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajay Chauhan  | Director | 10-Nov-1988 | Current |
| Anand Chauhan | Director | 10-Nov-1988 | Current |
Financial Performance of Pharmaplan India.
Pharmaplan India Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Pharmaplan India?
In 2017, Pharmaplan India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
_LIMITED.webp)
Technicom Chemie (India) LimitedAjay Chauhan and Anand Chauhan are mutual person
Kunstocom (India) LimitedAjay Chauhan and Anand Chauhan are mutual person
Krauter Babycare LimitedAjay Chauhan is a mutual person
Akc Data Systems (India) Private LimitedAjay Chauhan and Anand Chauhan are mutual person
Chabro Chemie India LimitedAjay Chauhan and Anand Chauhan are mutual person
- Amity Tv Network Private Limited
Ajay Chauhan and Anand Chauhan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pharmaplan India?
Unlock and access historical data on people associated with Pharmaplan India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmaplan India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmaplan India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.